Adocia SA (ADOC.PA)

EUR 3.85

(2.67%)

Operating Expenses Summary of Adocia SA

  • Adocia SA's latest annual operating expenses in 2023 was 15.62 Million EUR , down -102.8% from previous year.
  • Adocia SA's latest quarterly operating expenses in 2024 Q2 was 9.46 Million EUR , down 0.0% from previous quarter.
  • Adocia SA reported a annual operating expenses of 11.3 Million EUR in annual operating expenses 2022, down -42.16% from previous year.
  • Adocia SA reported a annual operating expenses of 19.54 Million EUR in annual operating expenses 2021, down -4.81% from previous year.
  • Adocia SA reported a quarterly operating expenses of 86 Thousand EUR for 2023 Q2, down -84.28% from previous quarter.
  • Adocia SA reported a quarterly operating expenses of 2.19 Million EUR for 2023 Q3, up 2450.0% from previous quarter.

Annual Operating Expenses Chart of Adocia SA (2023 - 2010)

Historical Annual Operating Expenses of Adocia SA (2023 - 2010)

Year Operating Expenses Operating Expenses Growth
2023 15.62 Million EUR -102.8%
2022 11.3 Million EUR -42.16%
2021 19.54 Million EUR -4.81%
2020 20.53 Million EUR -8.57%
2019 22.45 Million EUR -36.73%
2018 35.49 Million EUR -41.09%
2017 60.25 Million EUR -9.26%
2016 66.4 Million EUR 10.89%
2015 59.88 Million EUR 254.27%
2014 16.9 Million EUR -23.31%
2013 22.04 Million EUR -0.35%
2012 22.11 Million EUR 207.51%
2011 7.19 Million EUR -35.15%
2010 11.09 Million EUR 0.0%

Peer Operating Expenses Comparison of Adocia SA

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -274.168%
ABIVAX Société Anonyme 127.37 Million EUR 87.73%
Aelis Farma SA 18.81 Million EUR 16.951%
Biophytis S.A. 14.33 Million EUR -9.042%
Advicenne S.A. 8.21 Million EUR -90.25%
genOway Société anonyme 16.73 Million EUR 6.627%
IntegraGen SA 5.35 Million EUR -191.994%
Medesis Pharma S.A. 1.56 Million EUR -898.931%
Neovacs S.A. 10.34 Million EUR -51.099%
NFL Biosciences SA 4.37 Million EUR -257.287%
Plant Advanced Technologies SA 2.76 Million EUR -465.275%
Quantum Genomics Société Anonyme 1.71 Million EUR -809.739%
Sensorion SA 27.05 Million EUR 42.23%
Theranexus Société Anonyme 3 Million EUR -420.102%
TME Pharma N.V. 5.49 Million EUR -184.319%
Valbiotis SA 9.86 Million EUR -58.365%
TheraVet SA 1.64 Million EUR -850.488%
Valerio Therapeutics Société anonyme 20.32 Million EUR 23.086%
DBV Technologies S.A. 89.4 Million EUR 82.519%
Genfit S.A. 54.8 Million EUR 71.482%
GeNeuro SA 14.35 Million EUR -8.858%
Innate Pharma S.A. 64.57 Million EUR 75.795%
Inventiva S.A. 120.18 Million EUR 86.996%
MaaT Pharma SA 21.59 Million EUR 27.637%
MedinCell S.A. 32.92 Million EUR 52.527%
Nanobiotix S.A. 58.92 Million EUR 73.477%
OSE Immunotherapeutics SA 23.58 Million EUR 33.745%
Poxel S.A. 28.76 Million EUR 45.667%
GenSight Biologics S.A. 32.66 Million EUR 52.146%
Transgene SA 31.23 Million EUR 49.957%
Valneva SE 134.92 Million EUR 88.416%